← Back to Search

Pozzi for intrauterine insemination for Infertility

N/A
Waitlist Available
Led By Marie-Eve Bergeron, MD
Research Sponsored by CHU de Quebec-Universite Laval
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infertility :Defined as no pregnancy after one year of regular unprotected vaginal intercourse
Infertility secondary to endometriosis, to a mild to moderate male factor, to an ovulatory dysfunction, an unexplained infertility or any other known medical indication for IUI.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 months after positive pregnancy test
Awards & highlights

Study Summary

This trial is testing whether using a pozzi tenaculum forceps during intrauterine insemination boosts the rate of term live births.

Eligible Conditions
  • Infertility
  • Artificial Insemination

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 months after positive pregnancy test
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 months after positive pregnancy test for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of live births
Secondary outcome measures
Clinical rate of pregnancy (urinary or blood b-hcG)
Pain Level on visual analog scale
Patients' global satisfaction assessed by questionnaire

Trial Design

2Treatment groups
Active Control
Group I: Pozzi for intrauterine inseminationActive Control1 Intervention
Treatment done with a pozzi tenaculum forceps
Group II: No Pozzi for intrauterine inseminationActive Control1 Intervention
Treatment done without a tenaculum forceps

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalLead Sponsor
166 Previous Clinical Trials
106,194 Total Patients Enrolled
1 Trials studying Infertility
192 Patients Enrolled for Infertility
Marie-Eve Bergeron, MDPrincipal InvestigatorCHUL (CHUdeQuebec) - Département d'endocrinologie de la reproduction
1 Previous Clinical Trials
95 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I satisfy the prerequisites to participate in this trial?

"Patients aged 18 to 40 are eligible for this clinical trial, and 800 volunteers need to be recruited in total."

Answered by AI

Is this research endeavor open to seniors aged 85 and above?

"As stipulated in the study's criteria, only participants aged 18-40 are eligible to enroll."

Answered by AI

Is enrollment available for this investigation currently?

"Affirmative. Clinicaltrials.gov reports that this trial is currently recruiting participants; its inaugural posting was on the 1st of June 2019 and it has been recently revised as of 3rd February 2021. 800 volunteers are required from a single medical facility for this research study to proceed."

Answered by AI

How many participants are actively involved in this experiment?

"Affirmative, clinicaltrials.gov verifies that the trial is currently admitting participants. The study was initially advertised on June 1st 2019 and its parameters were last modified on February 3rd 2021. A total of 800 candidates are required at one medical facility."

Answered by AI
~139 spots leftby Mar 2025